The happy and bright group consists of people from varied backgrounds, ranging from biologists and pharmacists to medical doctors.
All emails are email@example.com with Scandinavian alphabets changed into their non-umlaut variants, unless otherwise stated. If in doubt on who to contact, please address the group leader, professor Esa Korpi.
MD, PhD, professor of pharmacology, group leader
Esa has published over 270 original articles and reviews in the fields of neuropsychopharmacology, biomedical alcohol research, neurobiology of addiction and brain diseases.
PhD (Pharm), adjunct professor (dosentti), senior lecturer
An expert on mouse behavioral pharmacology and intracerebral injections, Anni-Maija works as a principal investigator as well as the manager of the Rodent phenotyping and in vivo experimentation unit Rofe.
PhD, a postdoctoral researcher
On maternity leave from November 2017 onwards.
Elena is responsible for supervising drug-induced neuroplasticity studies and carrying out dopamine-GABA connectomics studies using electrophysiology and optogenetics.
Physiologist, PhD student
Elina is working on subtyping the VTA GABA neurons using a variety of electrophysiological techniques and patch-seq method to sample for single-cell RNA-sequence.
Pharmacist, PhD student
Lauri started in the lab by working on his master's thesis on chemogenetic modulation of behavior in GABA neuron-Cre mice. In his PhD project he will study the serotonergic modulation of reward circuitry and neuroplasticity.
Milo's work concentrates on stimulant and alcohol effects in rodent models.
Heidi is proficient in several critical laboratory techniques needed in Korpi lab, taking care of, among other things, perfusing brains, cutting brain sections, performing immunohistochemical and in situ hybridization experiments, counting the cell numbers, assisting in phenotyping of model systems and genotyping the mouse lines.
Worked on brain mechanisms of mania and hyperactivity using behavioral pharmacology, imaging and immediate early gene expression in animal models.
Bjørnar den Hollander
Worked on structural and behavioral neurotoxicity of novel designer drugs, using behavioral, neurochemical, imaging and mitochondrial functional methods.
Kati Hellsten (Saarelainen)
Worked on GABA-site agonists and specific GABAA receptor populations and anxiety mechanisms.